Medicare Enrolled
Dr. Carole Gordon, M.D.
Urology Physician · Oxford, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gordon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gordon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gordon
Dr. Carole Gordon is an urology physician in Oxford, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gordon performed 6,686 Medicare services across 3,208 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gordon received a total of $24,630 from 55 pharmaceutical and/or device companies across 334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gordon is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in FL
$24,630 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,686
Medicare services
Top 18% in FL for urology physician
3,208
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~352 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,821 | $2 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,267 | $65 | $227 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,250 | $0 | $1 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
544 | $49 | $159 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
319 | $8 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
293 | $90 | $320 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
183 | $63 | $606 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
172 | $6 | $6 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
157 | $110 | $422 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
132 | $11 | $35 |
| Injection of implant material into bladder or urethra A procedure where implant material is injected beneath the lining of the bladder and/or urethra using an endoscope. |
73 | $158 | $953 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
69 | $63 | $181 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
63 | $22 | $60 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
40 | $135 | $950 |
| Sacral nerve stimulator electrode insertion A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves. |
38 | $311 | $1,893 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
35 | $101 | $341 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
33 | $36 | $120 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
29 | $453 | $1,460 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
26 | $73 | $216 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
25 | $78 | $214 |
| Insertion of peripheral or gastric neurostimulator generator A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach. |
24 | $74 | $669 |
| Electronic analysis of implanted neurostimulator This procedure involves electronically analyzing an implanted neurostimulator generator and performing simple programming for spinal cord or peripheral nerve stimulation. |
22 | $34 | $125 |
| Bladder hernia repair into vaginal wall Surgical repair of a bladder hernia that has protruded into the vaginal wall. |
21 | $500 | $1,601 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
18 | $111 | $570 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
16 | $200 | $518 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $55 | $283 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
27.5% medium
71.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,630
Total received (2018-2024)
Avg $3,519/year across 7 years
Top 10% in FL for urology physician
55
Companies
334
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$17,873 (72.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,503 (26.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$254 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,904
2023
$1,705
2022
$969
2021
$971
2020
$733
2019
$515
2018
$10,832
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Avadel Specialty Pharmaceuticals, LLC
$9,630
Teleflex LLC
$8,297
Axonics, Inc.
$1,308
UroGPO LLC
$773
Sumitomo Pharma America, Inc.
$689
Astellas Pharma US Inc
$657
UROVANT SCIENCES INC
$274
ABBVIE INC.
$204
Valencia Technologies Corporation
$188
PFIZER INC.
$171
Boston Scientific Corporation
$169
Medtronic USA, Inc.
$165
TOLMAR Pharmaceuticals, Inc.
$148
Endo Pharmaceuticals Inc.
$139
Coloplast Corp
$127
C. R. Bard, Inc. & Subsidiaries
$123
SRS Medical Systems, Inc.
$114
Allergan, Inc.
$111
Janssen Biotech, Inc.
$101
UROGEN PHARMA, INC.
$83
Caldera Medical, Inc
$78
Axonics Modulation Technologies, Inc.
$76
BOSTON SCIENTIFIC CORPORATION
$75
Antares Pharma, Inc.
$68
UroGen Pharma, Inc.
$51
COLOPLAST CORP
$51
Bayer HealthCare Pharmaceuticals Inc.
$45
Myovant Sciences Inc.
$44
Tolmar, Inc.
$43
180 Medical, Inc.
$42
Dendreon Pharmaceuticals LLC
$40
DENTSPLY IH Inc.
$36
AbbVie, Inc.
$36
Medtronic, Inc.
$35
Allergan Inc.
$34
TherapeuticsMD, Inc.
$34
Cook Medical LLC
$32
Myriad Genetic Laboratories, Inc.
$31
Novartis Pharmaceuticals Corporation
$28
Alnylam Pharmaceuticals Inc.
$24
Telix Pharmaceuticals
$23
PALETTE LIFE SCIENCES, INC.
$23
Retrophin, Inc.
$21
PROCEPT BioRobotics Corporation
$21
Merck Sharp & Dohme LLC
$21
Baudax Bio Inc.
$19
Verity Pharmaceuticals Inc.
$18
Photocure Inc
$18
Travere Therapeutics, Inc.
$16
Laborie Medical Technologies Corp.
$15
ConvaTec Inc.
$14
Metuchen Pharmaceuticals
$13
Blue Earth Diagnostics Limited
$13
Acerus Pharmaceuticals Corporation
$12
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 78.1% of total payments
Associated products mentioned in payments ›
(815) Thiola · ANJESO · AVEED · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CONTINENCE CARE · Cook Medical NGage · Cysview · Desara · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL THERAPIES · GENERAL - KIDNEY STONE DISEASE · GREENLIGHT · GentleCath · ILLUCCIX · IMVEXXY · INTERSTIM · Inlay · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNX · LoFric · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · OBTRYX · ORGOVYX · OXLUMO · PLUVICTO · PROVENGE · Prolaris · REZUM · ReTrace · SOLESTA · SOLYX · SPEEDICATH · Spanner Prothetic Stent · Stendra · TOVIAZ · Trelstar · UROLIFT · UroCuff · UroLift System · XIAFLEX · XTANDI · XYOSTED · eCoin Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (73%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for urology physician in FL.
Equivalent to $368 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
32
Per 100K population
23.3
County median income
$73,297
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
12.2 mi
12.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gordon is a clinical cardiology specialist, with above-average Medicare volume (top 18% in FL), with consulting-driven industry engagement in the top 10% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gordon experienced with automated urinalysis?
Based on Medicare claims data, Dr. Gordon performed 1,821 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gordon receive payments from pharmaceutical companies?
Yes. Dr. Gordon received a total of $24,630 from 55 companies across 334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gordon's costs compare to other urology physicians in Oxford?
Dr. Gordon's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gordon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Oxford
Browse urology physicians in Oxford ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Avadel Specialty Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from Avadel Specialty Pharmaceuticals, LLC.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology